SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis.

ABSTRACT: The novel coronavirus can cause a severe respiratory disease with impact on the central nervous system, as has been reported by several medical health services. In the COVID-19 pandemic caused by the SARS-CoV-2 neurotrophic virus, neurologists have focused their attention on the early identification of suggestive manifestations of the neurological impact of the disease. In this context, they are exploring related chronic disease and the possibility of achieving a more effective understanding of symptoms derived from COVID-19 infection and those derived from the course of preexisting neurological disease. The present review summarizes evidence from the infection with SARS-CoV-2 and the management of the risks of multiple sclerosis and how it is related to the risks of general comorbidities

SUBMITTER: Diaz de la Fe A 

PROVIDER: S-EPMC8167598 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature